Innovative therapies for asthma: anti-IgE -- the future?
Weinberger
Miles
M
Pediatric Allergy & Pulmonary Division, University of Iowa College of Medicine, Iowa City, IA 52242, USA. miles-weinberger@uiowa.edu
D000485:Allergens / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D002648:Child; D002986:Clinical Trials as Topic; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D000069444:Omalizumab
D000485:Allergens; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C401983:rhuMAb-E25; D000069444:Omalizumab; D007073:Immunoglobulin E